Raffles Medial Group (RMG)

RHB has kept its "buy" call and target price at $1.75.

Raffles Medical is Maybank’s preferred pick in the healthcare sector.

This is the fifth consecutive month that the alpha picks portfolio has beaten the STI.

See the analysts' recommendations and target prices here.

CGS-CIMB Research upgrades recommendation on Raffles Medical to “add” from “hold” with a $1.22 target price.

See the analysts' recommendations and target prices here.

Following a share price correction, Maybank Kim Eng Research analyst Lai Gene Lih has upgraded Raffles Medical Group to “buy”.

Raffles Medical is looking to remain profitable in 2020, barring unforeseen circumstances like the prolongation of the novel coronavirus outbreak

SINGAPORE (20 Dec) : Eight in 10 medical practitioners say Singapore’s healthcare system should focus more on disease prevention as Singaporeans live longer and are more likely to contract a chronic illness at an earlier age. Moreover, nearly half or 49

SINGAPORE (July 29): Raffles Medical Group saw its earnings fall 15.6% to $14.2 million for the 2Q19 ended June 30, from $16.9 million a year ago, mainly due to gestation losses for Raffles Hospital Chongqing (RHCQ).